Trials / Conditions / Phenylketonuria (PKU)

Phenylketonuria (PKU)

23 registered clinical trials studyying Phenylketonuria (PKU) — 9 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Multiomics Approach in Adult Patients With Phenylketonuria NCT07484945	University Hospital, Tours	—
Not Yet Recruiting	The Psychosocial Functioning of Adults With Phenylketonuria. NCT07406009	Central Hospital, Nancy, France	—
Not Yet Recruiting	To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria NCT07318909	Gritgen Therapeutics Co., Ltd.	EARLY_Phase 1
Active Not Recruiting	Evaluation of BH4 Responsiveness in Our PKU Patients NCT07255599	Sohag University	Phase 1
Recruiting	A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria NCT06637514	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 2
Not Yet Recruiting	A Study to Evaluate the Long-Term Safety and Efficacy of JNT-517 in Participants With Phenylketonuria NCT06628128	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 3
Enrolling By Invitation	A Self-test Home-use Blood Phenylalanine Monitoring System Under the Brand Name Egoo Phe System Has Been Devel NCT06940193	Egoo Health Aps	—
Completed	PKU EASY Microtabs Plus - Acceptability and Tolerance NCT06694662	Galen Limited	N/A
Recruiting	Brain Aging in Phenylketonuria NCT06969209	Insel Gruppe AG, University Hospital Bern	—
Recruiting	A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisad NCT06305234	BioMarin Pharmaceutical	—
Active Not Recruiting	Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria NCT05270837	BioMarin Pharmaceutical	Phase 3
Recruiting	A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace) NCT05813678	BioMarin Pharmaceutical	—
Active Not Recruiting	AAV Gene Therapy Study for Subjects with PKU NCT04480567	BioMarin Pharmaceutical	Phase 1 / Phase 2
Completed	Iron Supplements Effect on b-Phe Levels in PKU Patients During 3 Years Study NCT06792240	ASST Santi Paolo e Carlo	Phase 2
Completed	PANDA: PKU Amino Acid Evaluation NCT04086511	Nutricia Research	—
Completed	Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU NCT03694353	BioMarin Pharmaceutical	Phase 3
Completed	A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults NCT03505125	BioMarin Pharmaceutical	—
Unknown	Body Composition, Energy Intake and Expenditure in People With Phenylketonuria NCT03309345	University of Glasgow	—
Completed	Impact of Phenylketonuria-type Diet on Appetite, Appetite Hormones and Diet Induced Thermogenesis NCT02440932	University of Glasgow	N/A
Completed	Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU NCT01889862	BioMarin Pharmaceutical	Phase 3
Terminated	A Pilot Study on Diurnal Variation NCT01806051	Dr. Linda Randolph	N/A
Completed	Simple Breath Test to Examine Phenylalanine Metabolism NCT02009904	University of British Columbia	—
Completed	Effects of Kuvan on Melatonin Secretion NCT01617070	University of Southern California	Phase 4